The DOI matches its Crossref record; 381 of the 381 references it cites were found in a registry or an index.
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
Open accessAbstract
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They are critical regulators of the intracellular concentrations of cAMP and cGMP as well as of their signaling pathways and downstream biological effects. PDEs have been exploited pharmacologically for more than half a century, and some of the most successful drugs worldwide today affect PDE function. Recently, mutations in PDE genes have been identified as causative of certain human genetic diseases; even more recently, functional variants of PDE genes have been suggested to play a potential role in predisposition to tumors and/or cancer, especially in cAMP-sensitive tissues. Mouse models have been developed that point to wide developmental effects of PDEs from heart function to reproduction, to tumors, and beyond. This review brings together knowledge from a variety of disciplines (biochemistry and pharmacology, oncology, endocrinology, and reproductive sciences) with emphasis on recent research on PDEs, how PDEs affect cAMP and cGMP signaling in health and disease, and what pharmacological exploitations of PDEs may be useful in modulating cyclic nucleotide signaling in a way that prevents or treats certain human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–381 of 381
Nagel, D. J., Aizawa, T., Jeon, K., Liu, W., Mohan, A. M., Wei, H., Miano, J. M., Florio, V. A., Gao, P., Korshunov, V. A., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000215576.27615.fd · Cited by 127
Deguchi, A., Thompson, W. J., & Weinstein, I. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3740 · Cited by 125
Horvath, A., Giatzakis, C., Tsang, K., Greene, E., Osório, P. D. S., Boikos, S. A., Libé, R., Patronas, Y., Robinson-White, A. J., Remmers, E. F., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.85 · Cited by 124
Self-citationCyclic Nucleotide Phosphodiesterase 1C Promotes Human Arterial Smooth Muscle Cell Proliferation
Rybalkin, S. D., Rybalkina, I. G., Beavo, J. A., & Bornfeldt, K. (2002) · Circulation Research · doi:10.1161/hh0202.104108 · Cited by 123
Groß-Langenhoff, M., Hofbauer, K., Weber, J. H., Schultz, A. C. F., & Schultz, J. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511468200 · Cited by 122
Zhong, N., & Zucker, R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3703-04.2005 · Cited by 121
Libé, R., Horvath, A., Vezzosi, D., Fratticci, A., Coste, J., Perlemoine, K., Ragazzon, B., Guillaud-Bataille, M., Groussin, L., Clauser, É., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1704 · Cited by 121
Self-citationLinglart, A., Fryssira, H., Hiort, O., Holterhus, P., de Nanclares, G. P., Argente, J., Heinrichs, C., Kuechler, A., Mantovani, G., Leheup, B., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2326 · Cited by 121
PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
Kehler, J., & Nielsen, J. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049624 · Cited by 121
Signal transducing membrane complexes of photoreceptor outer segments
Wensel, T. G. (2008) · Vision Research · doi:10.1016/j.visres.2008.03.010 · Cited by 120
The cAMP-specific Phosphodiesterase PDE4D3 Is Regulated by Phosphatidic Acid Binding
Grange, M., Sette, C., Cuomo, M., Conti, M., Lagarde, M., Prigent, A., & Némoz, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006329200 · Cited by 119
Dual PDE3/4 inhibitors as therapeutic agents for chronic obstructive pulmonary disease
Banner, K. H., & Press, N. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00170.x · Cited by 119
Role of vinpocetine in cerebrovascular diseases
Patyar, S., Prakash, A., Modi, M., & Medhi, B. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70574-6 · Cited by 118
Boswell‐Smith, V., Spina, D., Oxford, A. W., Comer, M., Seeds, E. A. M., & Page, C. P. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.099192 · Cited by 116
McCahill, A., McSorley, T., Huston, E., HILL, E., Lynch, M. J., Gall, I., Keryer, G., Lygren, B., Taskén, K., & Vanheeke, G. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.04.003 · Cited by 115
Horvath, A., Giatzakis, C., Robinson-White, A. J., Boikos, S. A., Levine, E., Griffin, K., Stein, E. V., Kamvissi, V., Soni, P., Bossis, I., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2914 · Cited by 114
Self-citationde Oliveira, S. K., Hoffmeister, M., Gambaryan, S. P., Müller‐Esterl, W., Guimarães, J. A., & Smolenski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610942200 · Cited by 111
Zoraghi, R., Bessay, E. P., Corbin, J. D., & Francis, S. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413611200 · Cited by 111
VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors
Favot, L., Keravis, T. M., Holl, V., Bec, A. L., & Lugnier, C. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0084 · Cited by 110
Richter, W., & Conti, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203585200 · Cited by 110
The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis
Snyder, P. B., Esselstyn, J. M., Loughney, K., Wolda, S. L., & Florio, V. A. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400362-jlr200 · Cited by 110
AKAPs: The architectural underpinnings of local cAMP signaling
Kritzer, M. D., Li, J., Dodge‐Kafka, K. L., & Kapiloff, M. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.05.002 · Cited by 109
Expression of cGMP-Specific Phosphodiesterase 9A mRNA in the Rat Brain
Andreeva, S. G., Dikkes, P., Epstein, P. M., & Rosenberg, P. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-22-09068.2001 · Cited by 107
PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model
Black, K. L., Yin, D., Ong, J. M., Hu, J., Konda, B. M., Wang, X., Ko, M. K., Bayan, J., Sacapano, M. R., Espinoza, A., et al. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.122 · Cited by 106
Aversa, A., Pili, M., Francomano, D., Bruzziches, R., Spera, E., Pera, G. L., & Spera, G. (2009) · International Journal of Impotence Research · doi:10.1038/ijir.2009.21 · Cited by 105
Tinsley, H. N., Gary, B. D., Keeton, A. B., Zhang, W., Abadi, A., Reynolds, R. C., & Piazza, G. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0758 · Cited by 105
Modulation of Leydig cell function by cyclic nucleotide phosphodiesterase 8A
Vasta, V., Shimizu‐Albergine, M., & Beavo, J. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609483103 · Cited by 105
Ghigo, A., Perino, A., Mehel, H., Zahradníková, A., Morello, F., Leroy, J., Nikolaev, V. O., Damilano, F., Cimino, J. J., Luca, E. D., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.114074 · Cited by 104
Role of phosphodiesterase 5 in synaptic plasticity and memory
Puzzo, D., Sapienza, S., Arancio, O., & Palmeri, A. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2447 · Cited by 104
Tsai, L.-C. L., Shimizu‐Albergine, M., & Beavo, J. A. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.069104 · Cited by 100
Kleiman, R. J., Kimmel, L. H., Bove, S. E., Lanz, T. A., Harms, J. F., Romegialli, A., Miller, K. S., Willis, A. D., Etages, S. D., Kuhn, M., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173294 · Cited by 99
Management of sexual dysfunction due to antipsychotic drug therapy
Schmidt, H. M., Hagen, M., Kriston, L., Soares‐Weiser, K., Maayan, N., & Berner, M. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003546.pub3 · Cited by 98
Phosphodiesterase 7A-Deficient Mice Have Functional T Cells
Yang, G., McIntyre, K. W., Townsend, R. M., Shen, H., Pitts, W. J., Dodd, J. H., Nadler, S. G., McKinnon, M., & Watson, A. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6414 · Cited by 98
Zhu, B., Vemavarapu, L. K., Thompson, W. J., & Strada, S. J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20286 · Cited by 97
Rothenbuhler, A., Horvath, A., Libé, R., Faucz, F. R., Fratticci, A., Raffin Sanson, M. L., Vezzosi, D., Azevedo, M., Levy, I., Almeida, M. Q., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04366.x · Cited by 96
Self-citationSildenafil Improves Health-Related Quality of Life in Patients With Pulmonary Arterial Hypertension*
Pepke‐Żaba, J., Gilbert, C. E., Collings, L., & Brown, M. C. J. (2008) · CHEST Journal · doi:10.1378/chest.07-0592 · Cited by 96
Huai, Q., Wang, H., Zhang, W., Colman, R. W., Robinson, H. H., & Ke, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401120101 · Cited by 95
Gardner, C., Robas, N. M., Cawkill, D., & Fidock, M. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2743 · Cited by 95
Genomic organization of the human phosphodiesterase PDE11A gene
Yuasa, K., Kanoh, Y., Okumura, K., et al. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01866.x · Cited by 94
TURKO, V. I., Sharron, H. F., & CORBIN, D. J. (1998) · Biochemical Journal · doi:10.1042/bj3290505 · Cited by 94
Hindmarch, I., Fuchs, H.-H., & Erzigkeit, H. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100610-00005 · Cited by 94
PKA and PDE4D3 anchoring to AKAP9 provides distinct regulation of cAMP signals at the centrosome
Terrin, A., Monterisi, S., Stangherlin, A., Zoccarato, A., Koschinski, A., Surdo, N. C., Mongillo, M., Sawa, A., Jordanides, N. E., Mountford, J. C., et al. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201201059 · Cited by 94
Spatial control of cAMP signalling in health and disease
Zaccolo, M. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.014 · Cited by 93
Vinpocetine as a potent antiinflammatory agent
Medina, A. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005138107 · Cited by 93
Giembycz, M. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.297 · Cited by 92
How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
Almeida, M. Q., & Stratakis, C. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.018 · Cited by 92
Self-citationMolecular organization of bovine rod cGMP-phosphodiesterase 6
Kameni-Tcheudji, J., Lebeau, L., Virmaux, N., Maftei, C. G., Cote, R., Lugnier, C., & Schultz, P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4813 · Cited by 92
Shepherd, M. C., Baillie, G. S., Stirling, D., & Houslay, M. D. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705770 · Cited by 91
Asmann, Y. W., Necela, B. M., Kalari, K. R., Hossain, A., Baker, T. R., Carr, J. M., Davis, C., Getz, J. E., Hostetter, G. H., Li, X., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3142 · Cited by 91
Reneerkens, O. A. H., Rutten, K., Bollen, E., Hage, T., Blokland, A., Steinbusch, H. W. M., & Prickaerts, J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.019 · Cited by 90
Tsutsui, M., Shimokawa, H., Otsuji, Y., & Yanagihara, N. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.010 · Cited by 89
Eukaryotic circadian systems: cycles in common
Dunlap, J., Loros, J., Liu, Y., & Crosthwaite, S. K. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00239.x · Cited by 88
Hunter, R. W., MacKintosh, C., & Hers, I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807536200 · Cited by 86
Phosphodiesterase 11 (PDE11) regulation of spermatozoa physiology
Wayman, C., Phillips, S., Lunny, C., et al. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901307 · Cited by 85
Kelly, M. P., Logue, S. F., Brennan, J. A., Day, J. P., Lakkaraju, S., Jiang, L., Zhong, X., Tam, M., Rizzo, S. J. S., Platt, B. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000730107 · Cited by 85
Cloning and characterization of two splice variants of human phosphodiesterase 11A
Hetman, J., Robas, N. M., Baxendale, R. W., Fidock, M. D., Phillips, S. C., Soderling, S. H., & Beavo, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200355397 · Cited by 84
Phosphodiesterase 4 and its inhibitors in inflammatory diseases
Jin, S.-L. C., Lin, S., & Ding, S.-L. (2012) · Biomedical Journal · doi:10.4103/2319-4170.106152 · Cited by 84
Michie, A. M., Lobban, M. D., Müller, T., Harnett, M. M., & Houslay, M. D. (1996) · Cellular Signalling · doi:10.1016/0898-6568(95)02032-2 · Cited by 84
McEwan, D. G., Brunton, V. G., Baillie, G. S., Leslie, N. R., Houslay, M. D., & Frame, M. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0097 · Cited by 84
Waddleton, D. M., Wu, W.-Z., Feng, Y., Thompson, C., Wu, M., Zhou, Y.-P., Howard, A., Thornberry, N., Li, J., & Mancini, J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.025 · Cited by 82
Begum, N., Hockman, S. C., & Manganiello, V. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.214155 · Cited by 82
Self-citationInhibition of Cyclic Nucleotide Phosphodiesterases by Methylxanthines and Related Compounds
Francis, S. H., Sekhar, K. R., Ke, H., & Corbin, J. D. (2010) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_4 · Cited by 81
Horvath, A., Korde, L. A., Greene, M. H., Libé, R., Osório, P. D. S., Faucz, F. R., Raffin‐Sanson, M. L., Tsang, K. M., Drori-Herishanu, L., Patronas, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0884 · Cited by 81
Self-citationSadhu, K., Hensley, K. M., Florio, V., & Wolda, S. L. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700707 · Cited by 80
Hu, H., McCaw, E. A., Hebb, A. L. O., Gomez, G. T., & Denovan‐Wright, E. M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03796.x · Cited by 78
Function and Dysfunction of CNG Channels: Insights from Channelopathies and Mouse Models
Biel, M., & Michalakis, S. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0025-y · Cited by 76
The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis
Schmidt, B. M. W., Kusma, M., Feuring, M., Timmer, W., Neuhäuser, M., Bethke, T. D., Stuck, B. A., Hörmann, K., & Wehling, M. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118596 · Cited by 75
Wakita, H., Tomimoto, H., Akiguchi, I., Lin, J.-X., Ihara, M., Ohtani, R., & Shibata, M. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.028 · Cited by 75
Phosphodiesterase 5 Inhibitors in Rapid Ejaculation: Potential Use and Possible Mechanisms of Action
Abdel‐Hamid, I. A. (2004) · Drugs · doi:10.2165/00003495-200464010-00002 · Cited by 75
Engels, P., Sullivan, M., Müller, T. M., & Lübbert, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01460-i · Cited by 74
Lefièvre, L., de Lamirande, E., & Gagnon, C. (2002) · Biology of Reproduction · doi:10.1095/biolreprod67.2.423 · Cited by 74
Sasaki, T., Kotera, J., & Omori, K. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610211 · Cited by 73
Rena, G., Begg, F., Ross, A. H., MacKenzie, C., McPhee, I., Campbell, L., Huston, E., Sullivan, M., & Houslay, M. D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12557-6 · Cited by 73
Rentero, C., Monfort, A., & Puigdomènech, P. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00021-4 · Cited by 72
3′,5′-Cyclic nucleotide phosphodiesterase 11A: localization in human tissues
Loughney, K., Taylor, J., & Florio, V. A. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901317 · Cited by 72
Dipyridamole prevents triple-negative breast-cancer progression
Spano, D., Marshall, J. –. A., Marino, N., Martino, D. D., Romano, A., Scoppettuolo, M. N., Bello, A. M., Dato, V. D., Navas, L., Vita, G. D., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9506-0 · Cited by 70
Phosphodiesterase 5 enzyme and its inhibitors: Update on pharmacological and therapeutical aspects
Kulkarni, S. K., & Patil, C. S. (2004) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2004.26.10.872561 · Cited by 70
PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER
Vang, A. G., Ben-Sasson, S. Z., Dong, H., Kream, B. E., DeNinno, M. P., Claffey, M. M., Housley, W., Clark, R. B., Epstein, P. M., & Brocke, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012011 · Cited by 70
New mouse models for recessive retinitis pigmentosa caused by mutations in the Pde6a gene
Sakamoto, K., McCluskey, M. P., Wensel, T. G., Naggert, J. Κ., & Nishina, P. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn327 · Cited by 70
Fujita, M., Hines, C. S., Zoghbi, S. S., Mallinger, A. G., Dickstein, L. P., Liow, J., Zhang, Y., Pike, V. W., Drevets, W. C., Innis, R. B., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.030 · Cited by 69
Signal integration through blending, bolstering and bifurcating of intracellular information
Pawson, C. T., & Scott, J. D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1843 · Cited by 69
Guipponi, M., Scott, H. S., Kudoh, J., Kawasaki, K., Shibuya, K., Shintani, A., Asakawa, S., Chen, H., Lalioti, M. D., Rossier, C., et al. (1998) · Human Genetics · doi:10.1007/s004390050838 · Cited by 68
Giembycz, M. A. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-041sr · Cited by 68
An anti-tumor role for cGMP-dependent protein kinase
Hou, Y., Gupta, N., Schoenlein, P. V., Wong, E., Martindale, R. G., Ganapathy, V., & Browning, D. D. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.08.035 · Cited by 67
Reneerkens, O. A. H., Rutten, K., Akkerman, S., Blokland, A., Shaffer, C. L., Menniti, F. S., Steinbusch, H. W. M., & Prickaerts, J. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.02.008 · Cited by 67
An update on new oral PDE5 inhibitors for the treatment of erectile dysfunction
Palit, V., & Ian Eardley, C. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.165 · Cited by 66
Phosphodiesterases as therapeutic targets
Lin, C., Xin, Z., Lin, G., & Lue, T. F. (2003) · Urology · doi:10.1016/s0090-4295(02)02439-1 · Cited by 66
Phosphodiesterase Inhibitors as Potential Cognition Enhancing Agents
Schmidt, C. J. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790411009 · Cited by 66
Marko, D., Romanakis, K., Zankl, H., Fürstenberger, G., Steinbauer, B., & Eisenbrand, G. (1998) · Cell Biochemistry and Biophysics · doi:10.1007/bf02737806 · Cited by 64
Molecular cloning of DNA encoding a calmodulin-dependent phosphodiesterase enriched in striatum.
Polli, J. W., & Kincaid, R. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11079 · Cited by 64
Zhang, H., Zhao, Y., Huang, Y., Deng, C., Hopper, A. T., Vivo, M. D., Rose, G. M., & O’Donnell, J. M. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0369-4 · Cited by 64
Expression of PDE11A in Normal and Malignant Human Tissues
D’Andrea, M. R., Qiu, Y., Haynes‐Johnson, D., et al. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6625.2005 · Cited by 64
Harndahl, L., Wierup, N., Enerbäck, S., Mulder, H., Manganiello, V., Sundler, F., Degerman, E., Bo, A.-R., & Holst, L. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308952200 · Cited by 63
Self-citationUys, G. M., Ramburan, A., Loos, B., Kinnear, C. J., Korkie, L., Mouton, J., Riedemann, J., & Moolman‐Smook, J. C. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-18 · Cited by 63
Stratakis, C. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.010 · Cited by 63
Self-citationDunkern, T. R., & Hatzelmann, A. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.07.007 · Cited by 62
Mathers, M. J., Klotz, T., Roth, S., Lümmen, G., & Sommer, F. O. (2009) · Andrologia · doi:10.1111/j.1439-0272.2008.00910.x · Cited by 62
Phosphodiesterase 8 (PDE8) regulates chemotaxis of activated lymphocytes
Dong, H., Osmanova, V., Epstein, P. M., & Brocke, S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.143 · Cited by 61
Molenaar, P., Christ, T., Hussain, R. I., Engel, A., Berk, E., Gillette, K., Chen, L., Galindo‐Tovar, A., Krobert, K. A., Ravens, U., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12167 · Cited by 60
Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A)
Yuasa, K., Ohgaru, T., Asahina, M., et al. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02366.x · Cited by 60
Wallace, D. A., Johnston, L. A., Huston, E., MacMaster, D., Houslay, T. M., Cheung, Y.-F., Campbell, L., Millen, J. E., Smith, R. A. J., Gall, I., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009423 · Cited by 59
Lipina, T. V., Palomo, V., Gil, C., Martínez, A., & Roder, J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.032 · Cited by 58
Natriuretic Peptides: Physiologic and Analytic Considerations
Omland, T., & Hagve, T. (2009) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.04.005 · Cited by 56
Young-Hun, C. H. O. I., Ekholm, D., Krall, J., Ahmad, F., Degerman, E., Manganiello, V. C., & Movsesian, M. A. (2000) · Biochemical Journal · doi:10.1042/bj3530041 · Cited by 54
Self-citationMichibata, H., Yanaka, N., Kanoh, Y., Okumura, K., & Omori, K. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00293-1 · Cited by 53
PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease
Diamant, Z., & Spina, D. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.12.011 · Cited by 53
PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries
Santos-Silva, A. J., Cairrão, E., Morgado, M., Álvarez, E., & Verde, I. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.017 · Cited by 52
Yang, S., Smotryski, J., McElroy, W. T., Tan, Z., Ho, G. D., Tulshian, D., Greenlee, W. J., Guzzi, M., Zhang, X., Mullins, D. E., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.11.023 · Cited by 51
Nunes, F., Ferreira-Rosa, K., Pereira, M. D. S., Kubrusly, R. C. C., Manhães, A. C., Abreu‐Villaça, Y., & Filgueiras, C. C. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.024 · Cited by 51
Francis, S. H., Morris, G. Z., & Corbin, J. D. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.4 · Cited by 50
Tsai, L.-C. L., Chan, G. C. ‐., Nangle, S. N., Shimizu‐Albergine, M., Jones, G. L., Storm, D. R., Beavo, J. A., & Zweifel, L. S. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00836.x · Cited by 49
McPhee, I., Cochran, S. M., & Houslay, M. D. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00217-0 · Cited by 49
Kanda, N., & Watanabe, S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00688-8 · Cited by 48
Wilmot-Roussel, H., Vezzosi, D., Rizk‐Rabin, M., Barreau, O., Ragazzon, B., René-Corail, F., de Reyniès, A., Bertherat, J. Y., & Assié, G. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4237 · Cited by 48
Signaling from β1‐ and β2‐adrenergic receptors is defined by differential interactions with PDE4
Richter, W., Day, P., Agrawal, R., Bruss, M. D., Granier, S., Wang, Y. L., Rasmussen, S. G. F., Horner, K., Wang, P., Lei, T., et al. (2008) · The FASEB Journal · doi:10.1096/fasebj.22.1_supplement.1046.7 · Cited by 48
Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer
Faucz, F. R., Horvath, A., Rothenbühler, A., Almeida, M. Q., Libé, R., Raffin‐Sanson, M., Bertherat, J. Y., Carraro, D. M., Soares, F. A., Molina, G. D. C., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1655 · Cited by 47
Self-citationNahrevanian, H. (2009) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702009000600010 · Cited by 47
Fleming, Y., Frame, M. C., & Houslay, M. D. (2004) · Journal of Cell Science · doi:10.1242/jcs.01096 · Cited by 47
Tenor, H., Hatzelmann, A., Beume, R., Lahu, G., Zech, K., & Bethke, T. D. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_3 · Cited by 46
Oishi, H., Takano, K.-I., Tomita, K., Takebe, M., Yokoo, H., Yamazaki, M., & Hattori, Y. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00363.2011 · Cited by 46
Begum, N., Shen, W., & Manganiello, V. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.006 · Cited by 46
Self-citationPotential therapeutic applications of phosphodiesterase inhibition in prostate cancer
Hamilton, T. K., Hu, N., Kolomitro, K., Bell, E. N., Maurice, D. H., Graham, C. H., & Siemens, D. R. (2012) · World Journal of Urology · doi:10.1007/s00345-012-0848-7 · Cited by 46
Relevant cAMP-Specific Phosphodiesterase Isoforms in Human Pituitary: Effect of Gsα Mutations
Persani, L., Borgato, S., Lania, A. G., Filopanti, M., Mantovani, G., Conti, M., & Spada, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7779 · Cited by 45
Hayashi, M., Shimada, Y., Nishimura, Y., Hama, T., & Tanaka, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02371-9 · Cited by 45
Ito, M., Nishikawa, M., Fujioka, M., Miyahara, M., Isaka, N., Shiku, H., & Nakano, T. (1996) · Cellular Signalling · doi:10.1016/s0898-6568(96)00112-x · Cited by 44
Houslay, M. D., & Baillie, G. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051333 · Cited by 44
Boikos, S. A., Horvath, A., Heyerdahl, S. L., Stein, E., Robinson-White, A. J., Bossis, I., Bertherat, J. Y., Carney, J. A., & Stratakis, C. A. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1076694 · Cited by 44
Self-citationCyclic Nucleotide Phosphodiesterase 3 Signaling Complexes
Ahmad, F., Degerman, E., & Manganiello, V. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1312646 · Cited by 42
Self-citationDunkerley, H. A., Tilley, D. G., Palmer, D., Liu, H., Jimmo, S. L., & Maurice, D. H. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.1033 · Cited by 42
Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?
Rizzo, M., Corrado, E., Patti, A. M., Rini, G. B., & Mikhailidis, D. P. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.557359 · Cited by 41
The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension
Schwarz, E. R. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6392 · Cited by 40
Keshavarzian, A., Mutlu, E., Guzman, J. P., Forsyth, C. B., & Banan, A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.9.1489 · Cited by 39
Muradov, K. G., Granovsky, A. E., & Artemyev, N. O. (2003) · Biochemistry · doi:10.1021/bi027095x · Cited by 38
Update on anaesthetic approach to pulmonary hypertension
Teo, Y. W., & Greenhalgh, D. (2010) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328335474e · Cited by 38
Epinephrine inhibits invasion of oral squamous carcinoma cells by modulating intracellular cAMP
Yamanaka, Y., Mammoto, T., Kirita, T., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00764-9 · Cited by 37
Mitsuhashi, N., Tanaka, Y., Kubo, S., Ogawa, S., Hayashi, C., Uchino, H., Shimizu, T., Watada, H., Kawasumi, M., Onuma, T., et al. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.545 · Cited by 37
Novel mutations of the PRKAR1A gene in patients with acrodysostosis
Muhn, F., Klopocki, E., Graul-Neumann, L. M., Uhrig, S., Colley, A., Castori, M., Lankes, E., Henn, W., Gruber‐Sedlmayr, U., Seifert, W., et al. (2013) · Clinical Genetics · doi:10.1111/cge.12106 · Cited by 36
Characterization of inhibitors of phosphodiesterase 1C on a human cellular system
Dunkern, T. R., & Hatzelmann, A. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06001.x · Cited by 36
Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility
Murata, K., Kameyama, M., Fukui, F., Ohigashi, H., Hiratsuka, M., Sasaki, Y., Kabuto, T., Mukai, M., Mammoto, T., Akedo, H., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006626529536 · Cited by 36
Phosphodiesterase 11 (PDE11): is it a player in human testicular function?
Francis, S. H. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901377 · Cited by 36
Acute heart failure: inotropic agents and their clinical uses
Endoh, M., & Hori, M. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.16.2179 · Cited by 36
PDE inhibitors: a new approach to treat metabolic syndrome?
Lugnier, C. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.012 · Cited by 36
McKenna, S. D., Pietropaolo, M., Tos, E. G., Clark, A. S., Fischer, D. J., Kagan, D., Bao, B., Chedrese, P. J., & Palmer, S. S. (2004) · Endocrinology · doi:10.1210/en.2004-0562 · Cited by 35
Ricardi, U., Gontero, P., Ciammella, P., Badellino, S., Valentino, F., Munoz, F., Guarneri, A., Rondi, N., Moretto, F., Filippi, A. R., et al. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01890.x · Cited by 33
cGMP‐dependent protein kinase II and aldosterone secretion
Spießberger, B., Bernhard, D., Herrmann, S., Feil, S. C., Werner, C. G., Luppa, P. B., & Hofmann, F. B. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06839.x · Cited by 33
Recent Progress in Heart Failure Treatment and Heart Transplantation
Augoustides, J. G., & Říha, H. (2009) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2009.06.009 · Cited by 33
PDE3 inhibition in dilated cardiomyopathy
Movsesian, M. A., Wever‐Pinzon, O., & Vandeput, F. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.09.001 · Cited by 31
Ekström, L., Schulze, J. J., Guillemette, C., Bélanger, A., & Rane, A. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328344c5c6 · Cited by 31
Houslay, M. D., & Baillie, G. S. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331333 · Cited by 31
Redondo, M., Palomo, V., Brea, J. M., Pérez, D. I., Martín-Álvarez, R., Pérez, C., Paúl-Fernández, N., Conde, S., Cadavid, M. I., Loza, M. I., et al. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300105c · Cited by 30
The Long and Short of Vascular Smooth Muscle Phosphodiesterase-4 As a Putative Therapeutic Target
Houslay, M. D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015719 · Cited by 29
Cabanero, M., Laje, G., Detera‐Wadleigh, S. D., & McMahon, F. J. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328320a3e2 · Cited by 28
Regulation of Adrenal Steroidogenesis by the High-affinity Phosphodiesterase 8 Family
Tsai, L.-C., & Beavo, J. A. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1321861 · Cited by 28
Sakakibara, H., Conti, M., & Weiner, R. (1998) · Neuroendocrinology · doi:10.1159/000054386 · Cited by 27
Phosphodiesterases link the aryl hydrocarbon receptor complex to cyclic nucleotide signaling
de Oliveira, S. K., & Smolenski, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.027 · Cited by 25
Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients
Peverelli, E., Ermetici, F., Filopanti, M., Elli, F. M., Ronchi, C. L., Mantovani, G., Ferrero, S., Bòsari, S., Beck‐Peccoz, P., Lania, A. G., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0677 · Cited by 25
Regulation of murine cardiac function by phosphodiesterases type 3 and 4
Beca, S., Aschar‐Sobbi, R., Panama, B. K., & Backx, P. H. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.017 · Cited by 25
Moreno‐López, B. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22353 · Cited by 25
PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women
Chen, C., Wickenheisser, J. K., Ewens, K. G., Ankener, W., Legro, R. S., Dunaif, A. E., McAllister, J. M., Spielman, R. S., & Strauss, J. F. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap035 · Cited by 24
Measuring Spatiotemporal Dynamics of Cyclic AMP Signaling in Real-Time Using FRET-Based Biosensors
Gesellchen, F., Stangherlin, A., Surdo, N. C., Terrin, A., Zoccarato, A., & Zaccolo, M. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-126-0_16 · Cited by 23
Ding, H., Du, W., Wang, H., Zhang, L., Wang, Z., Du, C., & Yan, T. (2012) · Urology · doi:10.1016/j.urology.2012.02.014 · Cited by 23
Phosphodiesterases and regulation of female reproductive function
Conti, M. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.10.004 · Cited by 22
Witwicka, H., Kobiałka, M., Siednienko, J., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.008 · Cited by 21
The role of milrinone in children with cardiovascular compromise: review of the literature
Meyer, S., Gortner, L., Brown, K., & Abdul‐Khaliq, H. (2011) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-011-0869-7 · Cited by 21
Role of cGMP in Sildenafil-Induced Activation of Endothelial Ca(2+)-Activated K(+) Channels
Luedders, D. W., Münz, B., Li, F., Rueckleben, S., Tillmanns, H., Waldecker, B., Wiecha, J., Erdoğan, A., Schaefer, C. A., & Kuhlmann, C. R. W. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000206438.35477.f2 · Cited by 21
Omar, B. A., Banke, E., Guirguis, E., Åkesson, L., Manganiello, V. C., Lyssenko, V., Groop, L., Gomez, M. F., & Degerman, E. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.157 · Cited by 20
Self-citationNew drug therapies for multiple sclerosis
Mangas, A., Coveñas, R., & Geffard, M. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833960f6 · Cited by 19
Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits
d’Esterre, C. D., & Lee, T. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05801.x · Cited by 17
Horvath, A., Faucz, F. R., Finkielstain, G. P., Nikita, M. E., Rothenbühler, A., Almeida, M. Q., Verónica Mericq, G., & Stratakis, C. A. (2010) · Thyroid · doi:10.1089/thy.2009.0260 · Cited by 15
Self-citationSällström, J., Jensen, B. L., Skøtt, O., Gao, X., & Persson, A. E. G. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.153 · Cited by 13
Inhibition of phosphodiesterase 11 (PDE11) impacts on sperm quality
Pomara, G., & Morelli, G. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901304 · Cited by 11
Potentiation of Ibudilast Inhibition of Platelet Aggregation in the Presence of Endothelial Cells
Rile, G., Yatomi, Y., Qi, R., Satoh, K., & Ozaki, Y. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00258-4 · Cited by 11
Degerman, E., & Manganiello, V. (2006) · CRC Press eBooks · doi:10.1201/9781420020847-5 · Cited by 10
Self-citationGreasing the protein biosynthesis machinery of photoreceptor neurons
Christiansen, J. R., & Ramamurthy, V. (2012) · Cellular Logistics · doi:10.4161/cl.19804 · Cited by 9
Lewis, R. J., Connor, J. T., Teerlink, J. R., Murphy, J. R., Cooper, L. T., Hiatt, W. R., & Brass, E. P. (2011) · Trials · doi:10.1186/1745-6215-12-134 · Cited by 9
“Shaping” of cell signaling via AKAP-tethered PDE4D: Probing with AKAR2-AKAP5 biosensor
Kocer, S. S., Wang, H., & Malbon, C. C. (2012) · Journal of Molecular Signaling · doi:10.1186/1750-2187-7-4 · Cited by 8
Deng, C., Wang, D., Bugaj‐Gaweda, B., & Vivo, M. D. (2007) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0721s38 · Cited by 7
Yoshida, H., Ashikawa, Y., Itoh, S., Nakagawa, T., ASANUMA, A., Tanabe, S., Inoue, Y. H., & Hidaka, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046432 · Cited by 7
Park, J. S., Lim, H.-J., Cho, Y., Lee, J. H., Yoon, H. I., & Lee, C. (2012) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.694922 · Cited by 7
NO-mediated cGMP synthesis in cultured cholinergic neurons from the basal forebrain of the fetal rat
de Vente, J., Abildayeva, K., van de Waarenburg, M. P. H., Ittersum, M. M., Steinbusch, H. W. M., & Mulder, M. T. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.089 · Cited by 5
Cited by
Herrmann, F. E., Hesslinger, C., Wollin, L., & Nickolaus, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.838449 · Cited by 137
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis
Kolb, M., Crestani, B., & Maher, T. M. (2023) · European Respiratory Review · doi:10.1183/16000617.0206-2022 · Cited by 85
Muo, I. M., MacDonald, S. D., Madan, R., Park, S.-J., Gharib, A. M., Martinez, P. E., Walter, M. F., Yang, S. B., Rodante, J. A., Courville, A. B., et al. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s182953 · Cited by 21
Metadata
- Authors
- Azevedo, M. F., Faucz, F. R., Bimpaki, E., Horvath, A., Levy, I., de Alexandre, R. B., Ahmad, F., Manganiello, V., & Stratakis, C. A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2013-12-05
- Volume
- 35
- Issue
- 2
- Pages
- 195-233
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2087208986
- Cited by
- 325
- References
- 381
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.